Immunotherapy of Recurrent Cervical Cancers Using Dendritic Cells (DCs)
NCT00155766
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Cervical Cancer
Interventions
BIOLOGICAL:
HPV16 E7 peptide-pulsed autologous DCs
Sponsor
National Taiwan University Hospital